Arrowhead Pharmaceuticals, Inc.
NASDAQ: ARWR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christopher R. Anzalone
- Employees
- 609
- Headquarters
- Pasadena, United States
- IPO year
- 1993
- Market cap
- $11.5B
- Website
- https://arrowheadpharma.com
Loading ARWR…
Loading profile data…Frequently asked questions about ARWR
What does Arrowhead Pharmaceuticals, Inc. (ARWR) do?
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology...
Where does ARWR trade?
Arrowhead Pharmaceuticals, Inc. (ARWR) trades on the NASDAQ Global Select.
What sector is ARWR in?
Arrowhead Pharmaceuticals, Inc. (ARWR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Arrowhead Pharmaceuticals, Inc.?
Christopher R. Anzalone is the chief executive officer of Arrowhead Pharmaceuticals, Inc. (ARWR).
Where is Arrowhead Pharmaceuticals, Inc. headquartered?
Arrowhead Pharmaceuticals, Inc. is headquartered in United States.
Does ARWR pay a dividend?
Arrowhead Pharmaceuticals, Inc. (ARWR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARWR go public?
Arrowhead Pharmaceuticals, Inc. (ARWR) completed its initial public offering in 1993.